# Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma

**Authors:** Duo Xu, Yanyun Gao, Shengchen Liu, Shiyuan Yin, Tong Hu, Haibin Deng, Tuo Zhang, Balazs Hegedüs, Thomas M Marti, Patrick Dorn, Shun-Qing Liang, Ralph A Schmid, Ren-Wang Peng, Yongqian Shu

PMC · DOI: 10.1038/s44321-025-00366-5 · EMBO Molecular Medicine · 2026-01-16

## Full-text entities

- **Genes:** NF2 (NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor) [NCBI Gene 4771] {aka ACN, BANF, SCH, SWNV, merlin-1}
- **Diseases:** mesothelioma (MESH:D008654)
- **Chemicals:** pyrimidine (MESH:C030986)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12905169/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12905169/full.md

---
Source: https://tomesphere.com/paper/PMC12905169